Search citation statements
Paper Sections
Citation Types
Year Published
Publication Types
Relationship
Authors
Journals
Summary Aims Diabetes screening strategies using glycated haemoglobin (HbA1c) as first‐instance diagnostic parameter may cause failure to detect individuals with abnormal glucose regulation and possible signs of microvascular complications despite “rule‐out” HbA1c levels. This cross‐sectional study examined the diagnostic performance of HbA1c in relation to fasting and two‐hour postload plasma glucose (FPG/2 h‐PG), and investigated whether individuals with normal HbA1c but abnormal FPG/2 h‐PG have a higher prevalence of moderately increased albuminuria as possible sign of early stage kidney damage. Methods A total of 2695 individuals (age 40‐79 years, 48% men) without prior diagnosis of diabetes and complete measurement of HbA1c, FPG, 2 h‐PG and urine albumin‐creatinine ratio (UACR) were taken from a large population‐based epidemiological study in the City of Leipzig, Germany. Results A total of 2439 individuals (90.5%, 95% CI: 89.4‐91.6) had normal HbA1c levels, <39 mmol/mol (<5.7%), while 234 (8.7%, 95% CI: 7.7‐9.8) had prediabetes, HbA1c ≥39 and <48 mmol/mol (≥5.7 and <6.5%), and 22 (0.8%, 95% CI: 0.5‐1.2) had diabetes, HbA1c ≥48 mmol/mol (≥6.5%), according to HbA1c. Among individuals with normal HbA1c, 35.6% (95% CI: 33.7‐37.5) had impaired fasting glucose or impaired glucose tolerance and 1.8% (95% CI: 1.4‐2.4) had diabetes according to FPG/2 h‐PG. Individuals with normal HbA1c but prediabetic or diabetic FPG/2 h‐PG had a significantly higher prevalence of moderately increased albuminuria (9.4%, 95% CI: 7.6‐11.5 and 13.3%, 95% CI: 5.8‐25.4, respectively) than individuals with normal HbA1c and normal FPG/2 h‐PG (3.9%, 95% CI: 3.0‐5.0). Conclusions The prevalence of prediabetes according to FPG/2 h‐PG among individuals with normal HbA1c is considerably high, and the prevalence of moderately increased albuminuria in this group is significantly elevated. Risk factors for diabetes such as age, gender and BMI may help to better identify this at‐risk group.
Summary Aims Diabetes screening strategies using glycated haemoglobin (HbA1c) as first‐instance diagnostic parameter may cause failure to detect individuals with abnormal glucose regulation and possible signs of microvascular complications despite “rule‐out” HbA1c levels. This cross‐sectional study examined the diagnostic performance of HbA1c in relation to fasting and two‐hour postload plasma glucose (FPG/2 h‐PG), and investigated whether individuals with normal HbA1c but abnormal FPG/2 h‐PG have a higher prevalence of moderately increased albuminuria as possible sign of early stage kidney damage. Methods A total of 2695 individuals (age 40‐79 years, 48% men) without prior diagnosis of diabetes and complete measurement of HbA1c, FPG, 2 h‐PG and urine albumin‐creatinine ratio (UACR) were taken from a large population‐based epidemiological study in the City of Leipzig, Germany. Results A total of 2439 individuals (90.5%, 95% CI: 89.4‐91.6) had normal HbA1c levels, <39 mmol/mol (<5.7%), while 234 (8.7%, 95% CI: 7.7‐9.8) had prediabetes, HbA1c ≥39 and <48 mmol/mol (≥5.7 and <6.5%), and 22 (0.8%, 95% CI: 0.5‐1.2) had diabetes, HbA1c ≥48 mmol/mol (≥6.5%), according to HbA1c. Among individuals with normal HbA1c, 35.6% (95% CI: 33.7‐37.5) had impaired fasting glucose or impaired glucose tolerance and 1.8% (95% CI: 1.4‐2.4) had diabetes according to FPG/2 h‐PG. Individuals with normal HbA1c but prediabetic or diabetic FPG/2 h‐PG had a significantly higher prevalence of moderately increased albuminuria (9.4%, 95% CI: 7.6‐11.5 and 13.3%, 95% CI: 5.8‐25.4, respectively) than individuals with normal HbA1c and normal FPG/2 h‐PG (3.9%, 95% CI: 3.0‐5.0). Conclusions The prevalence of prediabetes according to FPG/2 h‐PG among individuals with normal HbA1c is considerably high, and the prevalence of moderately increased albuminuria in this group is significantly elevated. Risk factors for diabetes such as age, gender and BMI may help to better identify this at‐risk group.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.